Significant Ownership of PAULSON & CO. INC.
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for PAULSON & CO. INC. focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Stuart L. Merzer - Stuart L. Merzer, General Counsel & Chief Compliance Officer
- Manager location
- Jersey City, NJ
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow PAULSON & CO. INC. and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from PAULSON & CO. INC.
Significant Ownership of PAULSON & CO. INC.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| THM | INTERNATIONAL TOWER HILL MINES LTD | Common Shares, no par value | 40% | $240,319,417 | +$11,301,430 | 104,486,703 | +4.9% | PAULSON & CO. INC. | 16 Apr 2026 |
| PPTA | Perpetua Resources Corp. | Common Shares without par value | 31% | $397,224,832 | 32,347,299 | PAULSON & CO. INC. | 10 Jun 2025 | ||
| THRY | Thryv Holdings, Inc. | Common stock, $0.01 par value per share (the "Common Stock") | 19% | $33,184,272 | +$16,363,872 | 8,443,835 | +97% | PAULSON & CO. INC. | 27 Feb 2026 |
| BHC | Bausch Health Companies Inc. | Common Shares, no par value | 19% | $468,403,853 | +$251,322,786 | 70,755,869 | +116% | PAULSON & CO. INC. | 14 Aug 2025 |
| AAMI | Acadian Asset Management Inc. | Common Stock, par value $0.001 per share (the "Common Stock") | 16% | $361,465,425 | -$117,534,000 | 5,843,282 | -25% | Paulson & Co. Inc. | 17 Jun 2026 |
| NG | NOVAGOLD RESOURCES INC | Common Shares, no par value | 9.8% | $191,942,693 | 39,988,061 | PAULSON & CO. INC. | 30 Jun 2025 | ||
| MDGL | Madrigal Pharmaceuticals, Inc. | Common Stock, $0.0001 par value per share | 6.1% | $743,261,329 | -$168,350,516 | 1,392,188 | -18% | PAULSON & CO. INC. | 31 Mar 2026 |
Schedules 13D/G Reported by PAULSON & CO. INC.:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.